Published in J Clin Periodontol on September 28, 2010
Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol (2011) 1.22
Rheumatoid arthritis and periodontitis - inflammatory and infectious connections. Review of the literature. J Oral Microbiol (2012) 1.14
Salivary biomarkers for detection of systemic diseases. PLoS One (2013) 1.13
Translational and clinical applications of salivary diagnostics. Adv Dent Res (2011) 1.08
Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther (2013) 1.05
Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol (2013) 0.94
Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysis. J Periodontal Implant Sci (2012) 0.86
Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Front Cell Infect Microbiol (2015) 0.84
Hand to Mouth: A Systematic Review and Meta-Analysis of the Association between Rheumatoid Arthritis and Periodontitis. Front Immunol (2016) 0.82
Point-of-care diagnosis of periodontitis using saliva: technically feasible but still a challenge. Front Cell Infect Microbiol (2015) 0.81
Protein biomarkers of periodontitis in saliva. ISRN Inflamm (2014) 0.78
Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study. PLoS One (2016) 0.77
Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8. J Mol Model (2014) 0.76
Rapid assessment of salivary MMP-8 and periodontal disease using lateral flow immunoassay. Oral Dis (2016) 0.75
Salivary TNFα levels in groups of subjects with rheumatoid arthritis and chronic periodontitis. BMC Res Notes (2017) 0.75
Oral manifestations of rheumatoid arthritis. A cross-sectional study of 73 patients. Clin Oral Investig (2016) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Development of a classification system for periodontal diseases and conditions. Ann Periodontol (1999) 12.48
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature (1986) 5.68
The diagnostic applications of saliva--a review. Crit Rev Oral Biol Med (2002) 3.41
Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem (2000) 2.80
Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 (2004) 2.57
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum (2010) 2.53
Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48
IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol (1998) 2.45
Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A (2007) 2.39
Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol (2009) 2.14
Analysis of saliva for periodontal diagnosis--a review. J Clin Periodontol (2000) 2.04
Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum (1997) 2.00
Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol (2008) 1.99
Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88
Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol (2007) 1.86
Current developments in salivary diagnostics. Biomark Med (2010) 1.83
Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol (2009) 1.72
Relationship between rheumatoid arthritis and periodontitis. J Periodontol (2001) 1.70
Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol (2000) 1.70
Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip (2005) 1.67
Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 (2009) 1.66
Saliva as a diagnostic fluid. BMJ (1992) 1.41
Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol (2006) 1.33
Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol (2007) 1.29
Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci (2007) 1.26
Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol (2003) 1.21
MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.19
Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol (2010) 1.12
Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci (1994) 1.06
Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch Oral Biol (1995) 1.01
Salivary biomarkers associated with alveolar bone loss. Ann N Y Acad Sci (2007) 1.00
Point detection of pathogens in oral samples. Adv Dent Res (2005) 0.99
Correlation between salivary IL-1beta levels and periodontal clinical status. Arch Oral Biol (2007) 0.95
Sialochemistry of patients with rheumatoid arthritis. Electrolytes, protein, and salivary IgA. Oral Surg Oral Med Oral Pathol (1978) 0.92
The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz) (2006) 0.91
Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis (1999) 0.90
Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease. J Periodontol (2009) 0.89
Alterations in cytokine profile and dendritic cells subsets in peripheral blood of rheumatoid arthritis patients before and after biologic therapy. Ann N Y Acad Sci (2009) 0.88
Salivary monitoring in oral diseases. Ann N Y Acad Sci (1993) 0.86
Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome. J Orofac Pain (2002) 0.84
Serum IL-1beta levels are associated with the presence of erosions in recent onset rheumatoid arthritis. Clin Exp Rheumatol (2007) 0.80
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet (2005) 10.11
Neuropathologic substrate of mild cognitive impairment. Arch Neurol (2006) 6.26
Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 (2005) 3.80
Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc (2007) 3.29
How practicing dentists can shape dental research: The American Association for Dental Research's vision for the future. J Am Dent Assoc (2012) 2.77
Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol (2007) 2.70
Patient perspectives on the impact of fibromyalgia. Patient Educ Couns (2008) 2.57
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum (2004) 2.48
Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain (2006) 2.31
Predicting risk of malignancy in adnexal masses. Obstet Gynecol (2010) 2.31
Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum (2008) 2.22
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Interference of cardiac pacemaker and implantable cardioverter-defibrillator activity during electronic dental device use. J Am Dent Assoc (2010) 2.04
Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum (2005) 1.98
Patterns of colorectal cancer incidence, risk factors, and screening in Kentucky. South Med J (2004) 1.94
Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol (2003) 1.94
Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88
Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol (2009) 1.87
Current developments in salivary diagnostics. Biomark Med (2010) 1.83
Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun (2007) 1.79
Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976) (2009) 1.79
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol (2013) 1.77
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol (2003) 1.75
Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol (2009) 1.73
Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol (2011) 1.72
Where are the diagnostic codes in dentistry? Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.68
Self-regulatory deficits in fibromyalgia and temporomandibular disorders. Pain (2010) 1.68
Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip (2005) 1.67
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.66
Lifelong bilingualism maintains neural efficiency for cognitive control in aging. J Neurosci (2013) 1.62
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62
Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer (2007) 1.61
The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer (2009) 1.59
Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum (2002) 1.58
Linking disease symptoms and subtypes with personalized systems-based phenotypes: a proof of concept study. Brain Behav Immun (2012) 1.53
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res (2012) 1.52
Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem (2009) 1.51
Fibromyalgia syndrome. J Rheumatol (2005) 1.49
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol (2005) 1.49
NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev (2005) 1.44
Effects of caloric restriction on inflammatory periodontal disease. Nutrition (2008) 1.43
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol (2013) 1.41
Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens (2008) 1.39
Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res (2008) 1.38
Relationships and our profession. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 1.37
Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia. Stat Med (2007) 1.36
High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol (2006) 1.34
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol (2002) 1.31
JC virus antibody status underestimates infection rates. Ann Neurol (2013) 1.30
Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement (2012) 1.28
Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. J Neurovirol (2005) 1.27
Antithrombotic agents: implications in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.26
Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci (2007) 1.26
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood (2002) 1.26
Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med (2003) 1.25
Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol (2011) 1.22
Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol 2000 (2003) 1.21
Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neurosci Lett (2008) 1.15
Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study. Prostaglandins Leukot Essent Fatty Acids (2007) 1.14
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain (2013) 1.13
A symptom-based approach to pharmacologic management of fibromyalgia. Nat Rev Rheumatol (2009) 1.13
Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther (2008) 1.11
Potential roles of microsomal prostaglandin E synthase-1 in rheumatoid arthritis. Inflamm Regen (2011) 1.11
Sleep stage dynamics in fibromyalgia patients and controls. Sleep Med (2008) 1.10
Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort. Neurodegener Dis (2010) 1.08
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol (2014) 1.07
A novel Brucella isolate in association with two cases of stillbirth in non-human primates - first report. J Med Primatol (2009) 1.07
JC virus detection in bodily fluids: clues to transmission. Clin Infect Dis (2006) 1.06
Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol (2010) 1.06
Periodontal disease immunology: 'double indemnity' in protecting the host. Periodontol 2000 (2013) 1.06
Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation (2008) 1.04
Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. J Alzheimers Dis (2011) 1.03
Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol (2012) 1.03
Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther (2013) 1.03
A multi-mode shock tube for investigation of blast-induced traumatic brain injury. J Neurotrauma (2011) 1.02
Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci (2011) 1.01
Mild cognitive impairment: statistical models of transition using longitudinal clinical data. Int J Alzheimers Dis (2012) 1.01
The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med (2007) 1.00
Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol (2009) 0.99
Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiol Aging (2011) 0.99